Lettmann Jason sold ALXO
August 17, 2026 · Form 4 insider transaction
Lettmann Jason sold 2,230 shares of ALX Oncology Holdings Inc. at $1.93 per share, a transaction worth $4.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,230
Price
$1.93
Total value
$4.3K
InsiderLettmann Jason
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 17, 2026
Filing dateAugust 18, 2026
Shares owned after294,379
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.; Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.